Bioavailability of riboflavin from a gastric retention formulation

International Journal of Pharmaceutics

Volumn 330, Issue 1-2, 2007, Pages 146-154

  Ahmed, Iman S ^a   Ayres, James W ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Bioavailability; Gastric retention; Riboflavin; Swellable systems

Indexed keywords

DODECYL SULFATE SODIUM; MACROGOL; POVIDONE; RIBOFLAVIN; XANTHAN;

ABDOMINAL RADIOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENDOSCOPY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INTESTINE TRANSIT TIME; MALE; MEAN RESIDENCE TIME; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH JUICE; TABLET DISINTEGRATION; URINARY EXCRETION;

ANIMALS; CAPSULES; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOGS; ENDOSCOPY; FEMALE; GASTROINTESTINAL TRACT; HUMANS; HYDROGELS; MALE; RANDOM ALLOCATION; RIBOFLAVIN; SOLUBILITY; VITAMIN B COMPLEX;

EID: 33846212310     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.021     Document Type: Article

References (42)

1. Akiyama K., Nagahara N., Nara E., Kitano M., Iwasa S., Yamamoto I., Azuma J., and Ogawa Y. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J. Pharm. Pharmacol. 50 (1997) 159-166
2. Atyabi F., Sharma H., Mohammad H.A.H., and Fell J.T. In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J. Control. Release 42 (1996) 105-113
3. Bates C.J. Bioavailability of riboflavin. Eur. J. Clin. Nutr. 51 (1997) 38-42
4. Caldwell, L.J., Gardner, C.R., Cargill, R.C., 1988. Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent 4735804.
5. Cargill R., Caldwell L.J., Engle K., Fix J.A., Porter P.A., and Gardner C.R. Controlled gastric emptying. 1. Effects of physical properties on gastric residence times of non-disintegrating geometric shapes in beagle dogs. Pharm. Res. 5 (1988) 533-536
6. Chandler M.L., and Guilford W.G. Assessment of gastric emptying and small intestinal transit in cats using radiopaque markers. J. Vet. Int. Med. 9 (1995) 192-195
7. Chen J., Blevins W.E., Park H., and Park K. Gastric retention properties of superporous hydrogel composites. J. Control. Release 64 (2000) 39-51
8. Christensen S. The biological fate of riboflavin in mammals. A survey of literature and own investigations. Acta Pharmacol. Toxicol. 32 (1973) 1-72
9. Dorkoosh F.A., Stokkel M.P., Blok D., Borchard G., Rafiee-Tehrani M., Verhoef J.C., and Junginger H.E. Feasibility study on the retention of superporous hydrogel composite polymer in the intestinal tract of man using scintigraphy. J. Control. Release 99 (2004) 199-206
10. Gemeinhart R.A., Park H., and Park K. Effect of compression on fast swelling of poly(acrylamide-co-acrylic acid) superporous hydrogels. J. Biomed. Mater. Res. 55 (2001) 54-62
11. Gillespie, W.R., 1992. PCDCON: Deconvolution for Pharmacokinetic Applications.
12. Harris D., Fell J.T., Sharma H.L., and Taylor D.C. GI transit of potential bioadhesive formulations in man: Scintigraphic study. J. Control. Release 12 (1990) 45-53
13. Hwang S.-J., Park H., and Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 243-284
14. Kawashima Y., Niwa T., Tadenchi H., Hino T., and Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 81 (1992) 135-140
15. Kedzierewicz F., Thouvenot P., Lemut J., Etienne A., Hoffmam M., and Maincent P. Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J. Control. Release 58 (1999) 195-205
16. Khattar D., Ahuja A., and Khar R.K. Hydrodynamically balanced systems as sustained release dosage forms for porpranolol hydrochloride. Pharmazie 45 (1990) 356-358
17. Khosla R., and Davis S.S. The effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol. 39 (1987) 47-49
18. Khosla R., and Davis S.S. Effect of tablet size on the gastric emptying of non-disintegrating tablets. Int. J. Pharm. 62 (1990) R9-R11
19. Klausner E.A., Lavy E., Stepensky D., Friedman M., and Hoffman A. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm. Res. 10 (2002) 1516-1523
20. Klausner E.A., Eyal S., Lavy E., Friedman M., and Hoffman A. Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. J. Control. Release 88 (2002) 117-126
21. Klausner E.A., Lavy E., Stepensky D., Cserepes E., Barta M., Friedman M., and Hoffman A. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers. J. Clin. Pharmacol. 43 (2003) 711-720
22. Klausner E.A., Lavy E., Barta M., Cserepes E., Friedman M., and Hoffman A. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans. Pharm. Res. 20 (2003) 1466-1473
23. Levy G., and Jusko W.J. Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 55 (1966) 285-289
24. Longer M.A., Ching H.S., and Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery III. Oral delivery of chlorothiazide using bioadhesive polymers. J. Pharm. Sci. 74 (1985) 406-411
25. Michaels, A.S., Bashaw, J.D., Zaffaroni, A., 1975. Gastro-inflatable drug delivery device. US Patent 3901232.
26. Moes A.J. Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier Syst. 10 (1993) 143-195
27. Oth M., Franz M., Timmermans J., and Moes A. The billeted floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. 9 (1992) 298-302
28. Park K., and Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 19 (1984) 107-127
29. Rudnic E.M., and Schwartz J.D. Oral solid dosage forms. Remington: The Science and Practice of Pharmacy. 20th ed. (2000), Lippincott Williams & Wilkins, Baltimore pp.885-888
30. Shalaby W.S.W., Blevins W.E., and Park K. Use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels. Biomaterials 13 (1992) 289-296
31. Shargel L., and Yu A. Applied Biopharmaceutics and Pharmacokinetics. fourth ed. (1985), Appleton & Lange, Stamford, Connecticut p. 252
32. Sheth P.R., and Tossounian J.L. The hydrodynamically balanced system (HBS), Novel drug delivery system for oral use. Drug Dev. Ind. Pharm. 10 (1984) 313-320
33. Smith M.D. Rapid method for determination of riboflavin in urine by HPLC. J. Chromatogr. 182 (1980) 285-291
34. Stops F., Fell J.T., Collett J.H., Martini L.G., Sharma H.L., and Smith A.M. Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state. Int. J. Pharm. 308 (2006) 14-24
35. Timmermans J., and Moes A.J. Cutoff size for gastric emptying of dosage forms. J. Pharm. Sci. 82 (1993) 854-859
36. Torrado S., Prada P., de la Torre P.M., and Torrado S. Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 25 (2004) 917-923
37. Vanderveen E., and Vanderveen J.E. Vitamins and other nutrients. Remington: The Science and Practice of Pharmacy. 20th ed. (2000), Lippincott Williams & Wilkins, Baltimore pp. 1796-1824
38. Wagner J.G. Fundamentals of clinical pharmacokinetics. second ed. (1979), The Hamilton Press, Inc., Hamilton, Illinois p. 342
39. Webb W.A. Management of foreign bodies of the upper gastrointestinal tract: update. Gastrointes. Endosc. 41 (1995) 39-51
40. Wek Z.P., Huang L., Ha J., and Li Y. Preparation of the 5-Fu floating sustained release tablet for gastric retention. Beijing Da Xue Xue Bao 36 (2004) 439-442
41. Williams M.F., Dukes G.E., Heizer W., Han Y., Herman D.J., Lampin T., and Hak L.J. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm. Res. 9 (1992) 1190-1194
42. Zempleni J., Galloway R., and McCormick D.B. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am. J. Clin. Nutr. 63 (1996) 54-66